Economic shot in the arm in Broadmeadows Hume Weekly Another plant due to open in 2015 will be used to manufacture Privigen - a plasma-derived immunoglobulin intravenous used to treat everything from primary immune deficiency to blood cancers and transplant rejection. The plant will eventually process ... |
